Comment on Rice ASC, Maton S, the Postherpetic Neuralgia Study Group (UK), gabapentin in postherpetic neuralgia: a randomized, double blind, placebo-controlled study

Affiliations

Comment

M Gehling et al. Pain. 2002 Apr.

. 2002 Apr;96(3):410-411.

doi: 10.1016/S0304-3959(02)00065-9.

¹ Department of Anesthesiology, Intensive Care and Pain Medicine, Klinikum Kassel, Moenchebergstrasse 41-43, D-34125 Kassel, Germany.

No abstract available

Comment on

What is a "clinically meaningful" reduction in pain?
Rowbotham MC. Rowbotham MC. Pain. 2001 Nov;94(2):131-132. doi: 10.1016/S0304-3959(01)00371-2. Pain. 2001. PMID: 11690725 Review. No abstract available.
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole MR. Farrar JT, et al. Pain. 2001 Nov;94(2):149-158. doi: 10.1016/S0304-3959(01)00349-9. Pain. 2001. PMID: 11690728 Clinical Trial.
Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study.
Rice ASC, Maton S; Postherpetic Neuralgia Study Group. Rice ASC, et al. Pain. 2001 Nov;94(2):215-224. doi: 10.1016/S0304-3959(01)00407-9. Pain. 2001. PMID: 11690735 Clinical Trial.

1. Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94:149-158.
1. Rice ASC, Maton S., Postherpetic Neuralgia Study Group. Gabapentin in postherpetic neuralgia: a randomized, double blind, placebo controlled study. Pain. 2001;94:215-224.
1. Rowbotham MC. Editorial: What is a ‘clinical meaningful’ reduction in pain? Pain. 2001;94:131-132.